Tuesday, August 21, 2018
Tags Immunotherapy

Tag: immunotherapy

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...

Merck’s Keytruda Shows Promise in Treating Advanced Melanoma

(Reuters) Merck & Co Inc said on Monday long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma patients, a day...

Mixed Results for Bristol/Nektar Combination in Cancer Trial

Chicago (Reuters) Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led...

Merck’s Keytruda Extends Lung Cancer Survival in Two Trials

By Deena Beasley CHICAGO (Reuters) Merck & Co's immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with chemotherapy for...

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...

Bluebird Myeloma Treatment Delays Cancer Progression: Trial

By Deena Beasley CHICAGO (Reuters) Patients with advanced multiple myeloma treated with Bluebird Bio's experimental immunotherapy lived for a median of nearly a year before...
banner